UniProt ID | UROK_HUMAN | |
---|---|---|
UniProt AC | P00749 | |
Protein Name | Urokinase-type plasminogen activator | |
Gene Name | PLAU | |
Organism | Homo sapiens (Human). | |
Sequence Length | 431 | |
Subcellular Localization | Secreted. | |
Protein Description | Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin.. | |
Protein Sequence | MRALLARLLLCVLVVSDSKGSNELHQVPSNCDCLNGGTCVSNKYFSNIHWCNCPKKFGGQHCEIDKSKTCYEGNGHFYRGKASTDTMGRPCLPWNSATVLQQTYHAHRSDALQLGLGKHNYCRNPDNRRRPWCYVQVGLKPLVQECMVHDCADGKKPSSPPEELKFQCGQKTLRPRFKIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
38 | Phosphorylation | CDCLNGGTCVSNKYF CCCCCCCCEECCCCC | 15.90 | - | |
38 | O-linked_Glycosylation | CDCLNGGTCVSNKYF CCCCCCCCEECCCCC | 15.90 | 2023947 | |
41 | Phosphorylation | LNGGTCVSNKYFSNI CCCCCEECCCCCCCC | 29.74 | - | |
44 | Nitration | GTCVSNKYFSNIHWC CCEECCCCCCCCEEE | 19.25 | - | |
158 | O-linked_Glycosylation | CADGKKPSSPPEELK CCCCCCCCCCHHHHH | 65.44 | 9765311 | |
158 | Phosphorylation | CADGKKPSSPPEELK CCCCCCCCCCHHHHH | 65.44 | 9765311 | |
159 | Phosphorylation | ADGKKPSSPPEELKF CCCCCCCCCHHHHHC | 53.66 | 29396449 | |
316 | Phosphorylation | FGTSCEITGFGKENS CCCCEEEECCCCCCC | 12.26 | 26074081 | |
322 | N-linked_Glycosylation | ITGFGKENSTDYLYP EECCCCCCCCCCCCH | 54.41 | UniProtKB CARBOHYD | |
323 | Phosphorylation | TGFGKENSTDYLYPE ECCCCCCCCCCCCHH | 24.60 | 2023947 | |
324 | Phosphorylation | GFGKENSTDYLYPEQ CCCCCCCCCCCCHHH | 40.00 | 26074081 | |
326 | Phosphorylation | GKENSTDYLYPEQLK CCCCCCCCCCHHHHH | 14.28 | 26074081 | |
328 | Phosphorylation | ENSTDYLYPEQLKMT CCCCCCCCHHHHHHH | 9.86 | 26074081 | |
335 | Phosphorylation | YPEQLKMTVVKLISH CHHHHHHHHHHHHCC | 22.14 | 26074081 | |
341 | Phosphorylation | MTVVKLISHRECQQP HHHHHHHCCCCCCCC | 27.25 | 26074081 | |
389 | Phosphorylation | CSLQGRMTLTGIVSW EEECCCEEEEEEEEE | 21.58 | 25002506 | |
391 | Phosphorylation | LQGRMTLTGIVSWGR ECCCEEEEEEEEECC | 18.72 | 25002506 | |
395 | Phosphorylation | MTLTGIVSWGRGCAL EEEEEEEEECCCCCC | 23.15 | 25002506 | |
424 | Ubiquitination | PWIRSHTKEENGLAL HHHHHCCCCCCCCCC | 58.57 | - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UROK_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PAI1_HUMAN | SERPINE1 | physical | 9184208 | |
GDN_HUMAN | SERPINE2 | physical | 9184208 | |
IPSP_HUMAN | SERPINA5 | physical | 2752144 | |
PAI2_HUMAN | SERPINB2 | physical | 8388810 | |
MP2K1_HUMAN | MAP2K1 | genetic | 10402467 | |
RASH_HUMAN | HRAS | genetic | 10402467 | |
UPAR_HUMAN | PLAUR | physical | 16879932 | |
PDGFC_HUMAN | PDGFC | physical | 22035541 | |
SCAM5_HUMAN | SCAMP5 | physical | 21163940 | |
ELAV1_HUMAN | ELAVL1 | physical | 14517288 | |
GDN_HUMAN | SERPINE2 | physical | 26186194 | |
MOCOS_HUMAN | MOCOS | physical | 26186194 | |
PP4R4_HUMAN | PPP4R4 | physical | 26186194 | |
GDN_HUMAN | SERPINE2 | physical | 28514442 | |
MOCOS_HUMAN | MOCOS | physical | 28514442 | |
KAT8_HUMAN | KAT8 | physical | 24953651 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
601709 | Quebec platelet disorder (QPD) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
O-linked Glycosylation | |
Reference | PubMed |
"Characterization of a posttranslational fucosylation in the growthfactor domain of urinary plasminogen activator."; Buko A.M., Kentzer E.J., Petros A., Menon G., Zuiderweg E.R.,Sarin V.K.; Proc. Natl. Acad. Sci. U.S.A. 88:3992-3996(1991). Cited for: PROTEIN SEQUENCE OF 21-43, GLYCOSYLATION AT THR-38, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Phosphorylation of human pro-urokinase on Ser138/303 impairs itsreceptor-dependent ability to promote myelomonocytic adherence andmotility."; Franco P., Iaccarino C., Chiaradonna F., Brandazza A., Iavarone C.,Mastronicola M.R., Nolli M.L., Stoppelli M.P.; J. Cell Biol. 137:779-791(1997). Cited for: PHOSPHORYLATION AT SER-158 AND SER-323, AND MUTAGENESIS OF SER-158 ANDSER-323. |